Lung protection in cardio-pulmonary bypass

Area of Science:

• Cardiovascular Surgery
• Pediatric Cardiac Surgery
• Pulmonary Medicine

Background:

• Cardiopulmonary bypass (CPB) is essential for complex pediatric cardiac malformations.
• CPB can cause ischemia-reperfusion injury to bypassed organs, including the lungs.
• The impact of CPB flow (pulsatile vs. non-pulsatile) and potential protective agents on lung injury requires further investigation.

Purpose of the Study:

• To evaluate the structural effects of CPB on lung tissue in a pediatric model.
• To assess the efficacy of pulsatile flow versus non-pulsatile flow during CPB in mitigating lung damage.
• To determine if the antibiotic minocycline can protect lung structure from CPB-induced injury.

Main Methods:

• A 90-minute CPB procedure was performed on 35 four-week-old piglets.
• Experimental groups included control, CPB with non-pulsatile flow, CPB with pulsatile flow, and minocycline administration in control and CPB groups.
• Lung biopsies were analyzed for histology, adenosine triphosphate content, and markers of hypoxia, apoptosis, nitrosative stress, inflammation, and DNA damage post-reperfusion.

Main Results:

• CPB induced significant alveolar wall thickening and neutrophil infiltration in the lungs.
• CPB elevated markers of hypoxia, apoptosis, nitrosative stress, inflammation, and DNA damage.
• Both pulsatile flow and minocycline partially inhibited these CPB-associated cellular damages.

Conclusions:

• CPB causes significant lung structural damage and cellular injury in a pediatric model.
• Pulsatile flow during CPB and administration of minocycline demonstrate a protective effect against CPB-induced lung injury.
• These findings suggest potential strategies to improve patient outcomes in pediatric cardiac surgery.